Trial · NCT07899619
Recovery Modalities and Application Sequence in Elite Female Basketball Players
NCT07899619, Not applicable, Enrolling by invitation, Medipol University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Recovery Modalities and Application Sequence in Elite Female Basketball Players. Trials, record NCT07899619. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07899619
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Recovery Modalities and Application Sequence in Elite Female Basketball Players
- NCT number
- NCT07899619
- Status
- Enrolling by invitation
- Phases
- Not applicable
- Enrollment
- 45 participants, estimated
- Lead sponsor
- Medipol University
- Conditions
- Basketball, Basketball Performance, Recovery, Recovery After Exercise
- Interventions
- Intermittent Pneumatic Compression (IPC), Local Heat and Mechanical Vibration (Venom 2 Leg), Passive Rest
- First posted
- 2026-10-27
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Post-Exercise Blood Lactate Concentration | At baseline, 3 minutes post-RAST, immediately post-first intervention, and at the end of the second intervention or passive recovery period. | Blood lactate measurement performed using a portable blood lactate analyzer from capillary blood samples obtained via fingertip puncture to evaluate the metabolic efficacy of recovery modalities following high-intensity anaerobic exercise (RAST). Measurement results are expressed in mmol/L. |
| Secondary | Lower Extremity Neuromuscular Performance (CMJ) | At baseline, 3 minutes post-RAST, immediately post-first intervention, and at the end of the second intervention or passive recovery period. | A vertical jump test conducted to evaluate lower extremity neuromuscular performance. Participants are asked to perform a maximum vertical jump with their hands on their hips. The average jump height of three trials is recorded in centimeters (cm). |
| Secondary | Perceived Recovery Status (PRS) | At baseline, 3 minutes post-RAST, immediately post-first intervention, and at the end of the second intervention or passive recovery period. | A single-item 0-10 point scale evaluating the subjective recovery level of athletes (0 = Very poorly recovered / Extremely tired, 10 = Completely recovered / Very well rested). Higher scores indicate better recovery status. |
| Secondary | Perceived Muscle Soreness (VAS) | At baseline, 3 minutes post-RAST, immediately post-first intervention, and at the end of the second intervention or passive recovery period. | A 10-cm visual analog scale evaluating the level of perceived lower extremity muscle soreness following exercise. 0 cm indicates 'no pain' and 10 cm indicates 'unbearable pain. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07899619
GET https://conductscience.org/api/trials/v1/NCT07899619/registered